Rare Protein Disorder Workshop To Address Treatment Development Challenges
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA-sponsored June 13-14 workshop will seek ways of facilitating development of treatments for small patient populations. The workshop will include presentations by Novo Nordisk, GTC Therapeutics, Baxter and ZLB Behring.